text: Diabetic dyslipidemia, yo, it's a condition, man,
  Where VLDL and chylomicrons go wild, fam,
  HDL-C levels drop, that ain't cool,
  sdLDL increases, postprandial lipemia rules.
  
  This profile's linked to metabolic syndrome, no joke,
  Risking atherosclerotic cardiovascular diseases, that's woke,
  Statin therapy's the first line of attack,
  Lowering atherogenic LDL, keepin' it on track.
  
  Clinical trials tried other lipid agents, true,
  But success varied depending on the crew,
  New insights on lipid metabolism are in sight,
  Especially for diabetic dyslipidemia, we gotta fight.
  
  So let's explore therapeutic strategies, gettin' advanced,
  Reducin' the risk, breakin' free from this resistant stance.